Nanomedicine News

RSS

Veritas Bio Granted European Patent for RNA Delivery

Veritas Bio, LLC, a privately held biotechnology company is pleased to announce that the European Patent Office (EPO) has granted a patent to Veritas for European Patent Application No. 07 873 598.2 1401. The patent relates to the “In vivo Delivery of Nucleic Acids.”

11 Sep 2013

Translational Data on Cerulean’s CRLX101 Polymeric Nanoparticle Candidate Published in PNAS

Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced the publication of translational data on the company's lead candidate, CRLX101, currently in Phase 2 trials. The study results, which are published in PNAS, indicate that animal pharmacokinetic and pharmacodynamic data are translatable to humans.

From Cerulean Pharma 11 Sep 2013

Superparamagnetic Iron Oxide Nanoparticles May Help Improve Assessment of Heart Attack Risk

A Binghamton University researcher hopes to give doctors a more accurate way of determining a patient’s risk of heart attack or stroke.

11 Sep 2013

New BIONOVA NANO SKIN TECH Solution for Dry Foot and Foot Inflammation

When it comes to beauty care, feet are not the first area to come to mind. The feet experience the most daily stress of wear and tear yet we often forget they need proper care, as well. Dry skin on the feet is the culprit of cracked heels, flakiness, itchiness and a burning sensation, which brings disruptive discomfort for a body area that is always in use.

10 Sep 2013

DNA Nanoparticles Reveal Critical Role of Protein STING

A little STING could go a long way in helping treat or even avoid autoimmune diseases such as arthritis, type 1 diabetes and multiple sclerosis, researchers report.

10 Sep 2013

Nanodiamonds Enable Direct Application of Chemotherapy to Brain Tumors

Researchers at UCLA’s Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

From University of California, Los Angeles 10 Sep 2013

Micromeritics Expert to Present at PDA Pharmaceutical Freeze Drying Conference in Dusseldorf, Germany

Micromeritics Scientist to present at the Parenteral Drug Association (PDA) Pharmaceutical Freeze Drying Conference taking place in Dusseldorf, Germany, September 24 – 25, 2013. Attendees to this conference includ...

From Micromeritics Instrument Corporation 9 Sep 2013

Virginia Tech Assistant Professor Develops New Flexible Microneedle Patch for Quicker Drug Delivery

An assistant professor with the Virginia Tech - Wake Forest School of Biomedical Engineering has developed a flexible microneedle patch that allows drugs to be delivered directly and fully through the skin. The new patch can quicken drug delivery time while cutting waste, and can likely minimize side-effects in some cases, notable in vaccinations and cancer therapy.

7 Sep 2013

New Nanotechnology Platform for Precise Eradication of Solid Tumors

ProScanRxPharma Inc. and Grafoid Inc announced today the formation of Calevia Inc., an entirely new cancer therapeutic nanotechnology platform for the precise targeting and thermal eradication of solid tumors.

6 Sep 2013

Scientists Develop Nano-Sized Form of Aspirin

Scientists are reporting development of a new form of aspirin — taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke — that could extend aspirin’s benefits to people who may not respond to the drug. Their advance toward coping with “aspirin resistance” appears in the journal ACS Nano.

From American Chemical Society 5 Sep 2013